Skip to main content
. 2006 Apr 1;6(12):1–97.

Table 5a: Characteristics of Non-Randomized Studies Excluded From the Review.

Study Enrolment period Design Sample size Type of lesion Intervention Strategy Follow-up-Months Primary End Point Secondary End points
Albiero et al 1993–95 Multicenter Case series (Retrospective) IVUS 158 Angio 154 De novo, native Stenting in all patients 6 6-month angiographic restenosis rate MACE, repeat PTCA & CABG
Blasini et al 1994-95 Single centre case series (Retrospective) IVUS 105 Angio 107 De novo, native, SVG, restenotic Stenting in all patients 6 6-month angiographic restenosis rate, MLD, % diameter stenosis  
Choi 1997 Single centre case series (Retrospective) IVUS 178 Angio 100 De novo, native Stenting in all patients 6 Resource utilization Death, MI, re PTCA, CABG, TVR, MACE
CRUISE Fitzgerald 2000 April 1996–May 1997 Prospective multicenter, observational; substudy of a RCT IVUS 270 Angio 229 De novo & restenotic, native coronary, up to 2 stents Stenting in all patients 9 Angiographic MSD & IVUS MSD & MSA @ 6 months MACE (death, MI, TVR) @ 9 months
PRESTO Orford 2004 ? Prospective multicenter, observational; substudy of a RCT IVUS 796 Angio 8,274 De novo &r restenotic, native coronary artery or vein graft lesions Stenting in all patients 9 Incidence of death, MI or ischemia driven TVR @ 9 months -

Angio angiography; IVUS intravascular ultrasound; MACE major adverse cardiac events; Ml myocardial infarction; PTCA percutaneous coronary interventions; CABG coronary artery bypass; TVR target vessel revascularization; MSD minimal stent diameter